- Lead drug substance team through preclinical and clinical development to commercialization across Astria's pipeline. The role will have end to end responsibility of drug substance process development and technical support.
- Drive, build, and enhance strategic relationships with CDMO and other partners to advance Astria's patient-guided drug development pipeline.
- Provide strategic and operational oversight, content creation of all regulatory documents and request for information.
- Partner cross functionally broadly throughout the organization including program teams, research, clinical development, medical affairs, new product planning, regulatory affairs, and corporate communications.
- Represent PharmSci holistically internally and externally as needed. Activities include due diligence, regulatory interactions, indication expansion, technology and innovation opportunities, project team and portfolio review committee.
- Develop, own, and execute against the operational budget pertaining to drug substance including manufacturing and process development.
- Provide mentorship and guidance to colleagues within the organization as well as outside of PharmSci.
- Ph.D. in biochemical engineering, chemical engineering, biochemistry, or appropriate technical discipline with 12-15 years industrial bioprocess development/scale-up and manufacturing experience. The ideal candidate would have extensive experience in cell line and upstream process development. BS/MS with minimum of 15-20 years relevant industrial experience
- 5 years' direct management experience is required.
- Strong leadership skills with experience defining the vision for the patient affairs function including strategic planning and supporting the development and growth of team members.
- Proven track record of building trusting, meaningful relationships with key stakeholders, cross functional organizations and CDMO vendors and partners
- Strong understanding of the legal, regulatory, and compliance environment, including a strong understanding of guidelines and best practices for drug substance development
- Highly collaborative, able to successfully develop and maintain strong working relationships cross-functionally with colleagues and with external stakeholders.
- Excellent communication and presentation skills
- Travel: 25% (domestic and international)
-
Director, Drug Substance Manufacturing
4 days ago
Rapport Therapeutics Boston, United StatesAs a word, Rapport describes relationships characterized by understanding, communication, teamwork, and trust. We reflect those qualities in our daily work, where we operate as one committed team that captures the collective knowledge and experience of all our members to maximall ...
-
Senior Director, Drug Substance
1 week ago
PepGen Boston, United StatesJob Description · Job DescriptionSenior Director, Drug Substance · Position Summary · Reporting to the VP, Head of CMC Development, the Senior Director, Drug Substance will be responsible for leading the drug substance team in development and manufacturing as part of PepGen ́s ...
-
Director of Drug Substance Manufacturing
1 week ago
QurAlis Cambridge, United StatesABOUT THE COMPANY · At QurAlis, we are neuro pioneers on a quest to cure. We work with a relentless pursuit of knowledge, a precise attention to craft, and an optimistic mindset to discover and develop effective precision medicines that will alter the trajectory of amyotrophic l ...
-
Director of Drug Substance Manufacturing
3 weeks ago
QurAlis Cambridge, United StatesABOUT THE COMPANY · QurAlis is a clinical-stage biotechnology company developing breakthrough precision medicines for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases with genetically validated targets. · QurAlis is trailblazing the path to conquering am ...
-
Director of Drug Substance Manufacturing
1 week ago
QurAlis Cambridge, United StatesABOUT THE COMPANY · Skills, Experience, Qualifications, If you have the right match for this opportunity, then make sure to apply today. · QurAlis is a clinical-stage biotechnology company developing breakthrough precision medicines for amyotrophic lateral sclerosis (ALS) and o ...
-
Director of Drug Substance Manufacturing
5 days ago
QurAlis Cambridge, United StatesABOUT THE COMPANY · QurAlis is a clinical-stage biotechnology company developing breakthrough precision medicines for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases with genetically validated targets. · QurAlis is trailblazing the path to conquering amy ...
-
Head of Drug Substance/CMC Lead
2 weeks ago
Cellarity Somerville, United StatesWhat if you could join a rapidly growing company and play a critical role in bringing new medicines to patients through looking at and treating disease in a revolutionary way? · What this position is all about: Cellarity is seeking a highly motivated and innovative Director/Senio ...
-
Director, Drug Substance Development
1 week ago
Kymera Therapeutics, Inc. Watertown, United StatesWho we are: · Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients' lives. Kymera is deploying TPD to address ...
-
Sail Biomedicines Cambridge, United StatesAssociate Director, Drug Substance Process Development · Sail Biomedicines is harnessing evolutionary and artificial intelligence to revolutionize programmable medicines. Sail's platform combines first-in-class programmable RNA technology (Endless RNA TM · or eRNA), and an indu ...
-
Senda Biosciences Cambridge, United StatesAbout Sail: · Sail Biomedicines is harnessing evolutionary and artificial intelligence to revolutionize programmable medicines. Sail's platform combines first-in-class programmable RNA technology (Endless RNATM or eRNA), and an industry-leading platform of programmable nanopartic ...
-
Senior Director, Drug Substance Development
1 week ago
Viridian Therapeutics Inc. Waltham, United States· At Viridian Therapeutics, we are focused on developing best-in-class medicines for people living with autoimmune and rare diseases. Leveraging our team's expertise in antibody discovery and engineering, we have created a robust pipeline of differentiated investigational therap ...
-
Senior Director, Drug Substance Development
1 week ago
Viridian Therapeutics, Inc Waltham, United StatesAt Viridian Therapeutics, we are focused on developing best-in-class medicines for people living with autoimmune and rare diseases. Leveraging our team's expertise in antibody discovery and engineering, we have created a robust pipeline of differentiated investigational therapeut ...
-
Senior Director, Drug Substance Development
2 weeks ago
Viridian Therapeutics Waltham, United StatesAt Viridian Therapeutics, we are focused on developing best-in-class medicines for people living with autoimmune and rare diseases. Leveraging our team's expertise in antibody discovery and engineering, we have created a robust pipeline of differentiated investigational therapeut ...
-
Senior Director, Drug Substance Development
5 days ago
Viridian Therapeutics Waltham, United StatesAt Viridian Therapeutics, we are focused on developing best-in-class medicines for people living with autoimmune and rare diseases. Leveraging our team's expertise in antibody discovery and engineering, we have created a robust pipeline of differentiated investigational therapeut ...
-
Drug Substance Business Standards Lead
1 week ago
Moderna, Inc. Norwood, United StatesThe Role: · The Drug Substance Business Standards Lead is responsible for driving standardization of business processes and systems across the Global Drug Substance Network, with an emphasis on simple, robust solutions that fit the organization's broad mission. This role involves ...
-
Drug Substance Business Standards Lead
3 weeks ago
Moderna Norwood, United StatesDrug Substance Business Standards Lead page is loaded · Drug Substance Business Standards Lead · Apply · locations · Norwood, Massachusetts · Drug Manufacturing · time type · Full time · posted on · Posted 4 Days Ago · job requisition id · R15407 · The Role: · The Dru ...
-
Drug Substance Business Standards Lead
1 week ago
BioSpace Norwood, United StatesJob Details · The Role: · The Drug Substance Business Standards Lead is responsible for driving standardization of business processes and systems across the Global Drug Substance Network, with an emphasis on simple, robust solutions that fit the organizations broad mission. This ...
-
Drug Substance Business Standards Lead
1 week ago
Moderna Theraputics Norwood, United StatesThe Role: · The Drug Substance Business Standards Lead is responsible for driving standardization of business processes and systems across the Global Drug Substance Network, with an emphasis on simple, robust solutions that fit the organization's broad mission. This role involves ...
-
Project Manager, Drug Substance Operations
3 weeks ago
Moderna Norwood, United StatesThe Role: · Moderna is seeking a Project Manager within the Drug Substance Business Unit. This position is responsible to drive a variety of cross-functional projects across the Business Unit, enabling the implementation of new technologies, expansion of manufacturing capacity, ...
-
Drug Substance Business Standards Lead
1 week ago
Moderna Theraputics Norwood, United StatesThe Role: The Drug Substance Business Standards Lead is responsible for driving standardization of business processes and systems across the Global Drug Substance Network, with an emphasis on simple, robust solutions that fit the organization's broad mission. This role involves l ...
Senior Director, Head of Drug Substance - Boston, United States - Astria Therapeutics, Inc.
Description
Title: Senior Director, Head of Drug Substance
Position Overview:
Astria Therapeutics is dedicated to bringing hope with life-changing therapies to patients and families affected by allergic and immunological diseases. Astria's pipeline includes our lead program, STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein in clinical development for the treatment of hereditary angioedema, as well as STAR-0310, an OX40 monoclonal antibody antagonist currently in pre-clinical development for atopic dermatitis (AD) and being explored for other allergic and immunological diseases.
We are seeking an experienced leader to join Astria as the Senior Director, Head of Drug Substance. This role will oversee all drug substance process development for the company and will play a key role in driving the portfolio forward from early process development through late stage, including process characterization, validation, and commercialization. The Head of Drug Substance will have a pivotal role in providing strategy, shaping future organizational design, and innovation for the PharmSci organization. This senior leadership position requires a strategic thinker with a deep understanding of development, including late stage and commercialization, exceptional relationship building, technical skills, and the ability to collaborate cross-functionally to ensure efficient and effective development throughout our programs at Astria. This role will also oversee all aspects of drug substance process and technology development and be a key partner for the other PharmSci functional heads. This leader will initially manage a small team of vendors and internal reports with an opportunity for future growth and reports to the SVP of Pharmaceutical Sciences and Technical Operations.
Responsibilities:
Qualifications:
Astria's Commitment:
At Astria, we are committed to building a diverse team where every Astrian is empowered to bring their authentic self to work. We embrace a patient-first, people-always culture in which all Astrians and our collaborators have a sense of belonging and receive the support they need to thrive. We invest in our people through our words, our actions, and our values. We are working to develop and implement initiatives that promote diversity, equity, and inclusion throughout the organization and foster a culture of openness, respect, and collaboration, where all voices are heard, and everyone is valued for their unique perspectives and contribution.
People are our greatest asset, and only with a diverse team can Astria shine brighter. Together we can bring our passion and compassion to the work of delivering life-changing therapies to patients, families and communities.
Senior Director, Head of Drug Substance professionals in Boston
-
Bryan Paul
Sr Cybersecurity Professional